Condition
Mesothelioma
Estimated Enrollment: 336
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Participant, Care Provider, Investigator, Outcomes Assessor|Primary Purpose: Treatment
Study ID Numbers: 22864|2016-003111-35|CA290841|A21400
Study First Received: February 10, 2017
Last Updated: April 11, 2017
Estimated Primary Completion Date: June 2021
Primary Outcome Measures:
Overall survival|modified RECIST or RECIST 1.1 – progression free survival|modified RECIST or RECIST 1.1 – overall response rate|EQ-5D-5L|CTCAE V4.03|Health resource use questionnaire
Sponsors and Collaborators:
University of Southampton|University of Leicester|University of Sheffield|Queen Mary University of London|Queen’s University, Belfast|Velindre NHS Trust|Beatson West of Scotland Cancer Centre
Website Link: https://ClinicalTrials.gov/show/NCT03063450
